Table 3.
Comb-p differentially methylated region analysis.
Region | CpG sites in region | p value | Adjusted p value |
---|---|---|---|
CD-associated DMRs | |||
Chr1: 2230601–2230924 | 4 | 7.66e–12 | 2.09e–06 |
Chr14: 24540174–24540453 | 4 | 3.44e–09 | 0.001087 |
Chr11: 65546988–65547173 | 4 | 1.02e–08 | 0.004868 |
Chr2: 128458240–128458402 | 5 | 5.18e–25 | 2.82e–19 |
Chr6: 6588693–6589076 | 5 | 1.11e–16 | 2.56e–11 |
Chr22: 45608345–45608714 | 10 | 3.60e–15 | 8.50e–10 |
Chr6: 30297174–30297628 | 11 | 1.88e–18 | 3.65e–13 |
UC-associated DMRs | |||
Chr2: 128458240–128458402 | 5 | 9.30e–13 | 5.07e–07 |
Chr6: 30297257–30297628 | 10 | 2.61e–11 | 6.21e–06 |
CD, Crohn’s disease; UC, ulcerative colitis.
p value, slk-corrected p value; Adjusted p value, one-step Šidák multiple-testing correction.
Differentially methylated regions associated with IBD are highlighted in bold.